1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global After Acute Ischemic Stroke Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antihypertensive Therapeutics 1.2.3 Antiplatelet Therapeutics 1.2.4 Anticoagulants 1.3 Market by Application 1.3.1 Global After Acute Ischemic Stroke Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Center 1.3.4 Diagnostic Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global After Acute Ischemic Stroke Market Perspective (2016-2027) 2.2 After Acute Ischemic Stroke Growth Trends by Regions 2.2.1 After Acute Ischemic Stroke Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 After Acute Ischemic Stroke Historic Market Share by Regions (2016-2021) 2.2.3 After Acute Ischemic Stroke Forecasted Market Size by Regions (2022-2027) 2.3 After Acute Ischemic Stroke Industry Dynamic 2.3.1 After Acute Ischemic Stroke Market Trends 2.3.2 After Acute Ischemic Stroke Market Drivers 2.3.3 After Acute Ischemic Stroke Market Challenges 2.3.4 After Acute Ischemic Stroke Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top After Acute Ischemic Stroke Players by Revenue 3.1.1 Global Top After Acute Ischemic Stroke Players by Revenue (2016-2021) 3.1.2 Global After Acute Ischemic Stroke Revenue Market Share by Players (2016-2021) 3.2 Global After Acute Ischemic Stroke Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by After Acute Ischemic Stroke Revenue 3.4 Global After Acute Ischemic Stroke Market Concentration Ratio 3.4.1 Global After Acute Ischemic Stroke Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by After Acute Ischemic Stroke Revenue in 2020 3.5 After Acute Ischemic Stroke Key Players Head office and Area Served 3.6 Key Players After Acute Ischemic Stroke Product Solution and Service 3.7 Date of Enter into After Acute Ischemic Stroke Market 3.8 Mergers & Acquisitions, Expansion Plans 4 After Acute Ischemic Stroke Breakdown Data by Type 4.1 Global After Acute Ischemic Stroke Historic Market Size by Type (2016-2021) 4.2 Global After Acute Ischemic Stroke Forecasted Market Size by Type (2022-2027) 5 After Acute Ischemic Stroke Breakdown Data by Application 5.1 Global After Acute Ischemic Stroke Historic Market Size by Application (2016-2021) 5.2 Global After Acute Ischemic Stroke Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America After Acute Ischemic Stroke Market Size (2016-2027) 6.2 North America After Acute Ischemic Stroke Market Size by Type 6.2.1 North America After Acute Ischemic Stroke Market Size by Type (2016-2021) 6.2.2 North America After Acute Ischemic Stroke Market Size by Type (2022-2027) 6.2.3 North America After Acute Ischemic Stroke Market Size by Type (2016-2027) 6.3 North America After Acute Ischemic Stroke Market Size by Application 6.3.1 North America After Acute Ischemic Stroke Market Size by Application (2016-2021) 6.3.2 North America After Acute Ischemic Stroke Market Size by Application (2022-2027) 6.3.3 North America After Acute Ischemic Stroke Market Size by Application (2016-2027) 6.4 North America After Acute Ischemic Stroke Market Size by Country 6.4.1 North America After Acute Ischemic Stroke Market Size by Country (2016-2021) 6.4.2 North America After Acute Ischemic Stroke Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe After Acute Ischemic Stroke Market Size (2016-2027) 7.2 Europe After Acute Ischemic Stroke Market Size by Type 7.2.1 Europe After Acute Ischemic Stroke Market Size by Type (2016-2021) 7.2.2 Europe After Acute Ischemic Stroke Market Size by Type (2022-2027) 7.2.3 Europe After Acute Ischemic Stroke Market Size by Type (2016-2027) 7.3 Europe After Acute Ischemic Stroke Market Size by Application 7.3.1 Europe After Acute Ischemic Stroke Market Size by Application (2016-2021) 7.3.2 Europe After Acute Ischemic Stroke Market Size by Application (2022-2027) 7.3.3 Europe After Acute Ischemic Stroke Market Size by Application (2016-2027) 7.4 Europe After Acute Ischemic Stroke Market Size by Country 7.4.1 Europe After Acute Ischemic Stroke Market Size by Country (2016-2021) 7.4.2 Europe After Acute Ischemic Stroke Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific After Acute Ischemic Stroke Market Size (2016-2027) 8.2 Asia-Pacific After Acute Ischemic Stroke Market Size by Type 8.2.1 Asia-Pacific After Acute Ischemic Stroke Market Size by Type (2016-2021) 8.2.2 Asia-Pacific After Acute Ischemic Stroke Market Size by Type (2022-2027) 8.2.3 Asia-Pacific After Acute Ischemic Stroke Market Size by Type (2016-2027) 8.3 Asia-Pacific After Acute Ischemic Stroke Market Size by Application 8.3.1 Asia-Pacific After Acute Ischemic Stroke Market Size by Application (2016-2021) 8.3.2 Asia-Pacific After Acute Ischemic Stroke Market Size by Application (2022-2027) 8.3.3 Asia-Pacific After Acute Ischemic Stroke Market Size by Application (2016-2027) 8.4 Asia-Pacific After Acute Ischemic Stroke Market Size by Region 8.4.1 Asia-Pacific After Acute Ischemic Stroke Market Size by Region (2016-2021) 8.4.2 Asia-Pacific After Acute Ischemic Stroke Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America After Acute Ischemic Stroke Market Size (2016-2027) 9.2 Latin America After Acute Ischemic Stroke Market Size by Type 9.2.1 Latin America After Acute Ischemic Stroke Market Size by Type (2016-2021) 9.2.2 Latin America After Acute Ischemic Stroke Market Size by Type (2022-2027) 9.2.3 Latin America After Acute Ischemic Stroke Market Size by Type (2016-2027) 9.3 Latin America After Acute Ischemic Stroke Market Size by Application 9.3.1 Latin America After Acute Ischemic Stroke Market Size by Application (2016-2021) 9.3.2 Latin America After Acute Ischemic Stroke Market Size by Application (2022-2027) 9.3.3 Latin America After Acute Ischemic Stroke Market Size by Application (2016-2027) 9.4 Latin America After Acute Ischemic Stroke Market Size by Country 9.4.1 Latin America After Acute Ischemic Stroke Market Size by Country (2016-2021) 9.4.2 Latin America After Acute Ischemic Stroke Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa After Acute Ischemic Stroke Market Size (2016-2027) 10.2 Middle East & Africa After Acute Ischemic Stroke Market Size by Type 10.2.1 Middle East & Africa After Acute Ischemic Stroke Market Size by Type (2016-2021) 10.2.2 Middle East & Africa After Acute Ischemic Stroke Market Size by Type (2022-2027) 10.2.3 Middle East & Africa After Acute Ischemic Stroke Market Size by Type (2016-2027) 10.3 Middle East & Africa After Acute Ischemic Stroke Market Size by Application 10.3.1 Middle East & Africa After Acute Ischemic Stroke Market Size by Application (2016-2021) 10.3.2 Middle East & Africa After Acute Ischemic Stroke Market Size by Application (2022-2027) 10.3.3 Middle East & Africa After Acute Ischemic Stroke Market Size by Application (2016-2027) 10.4 Middle East & Africa After Acute Ischemic Stroke Market Size by Country 10.4.1 Middle East & Africa After Acute Ischemic Stroke Market Size by Country (2016-2021) 10.4.2 Middle East & Africa After Acute Ischemic Stroke Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Details 11.1.2 Bayer Business Overview 11.1.3 Bayer After Acute Ischemic Stroke Introduction 11.1.4 Bayer Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.1.5 Bayer Recent Development 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Details 11.2.2 Boehringer Ingelheim Business Overview 11.2.3 Boehringer Ingelheim After Acute Ischemic Stroke Introduction 11.2.4 Boehringer Ingelheim Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.2.5 Boehringer Ingelheim Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche After Acute Ischemic Stroke Introduction 11.3.4 Roche Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.3.5 Roche Recent Development 11.4 Sanofi 11.4.1 Sanofi Company Details 11.4.2 Sanofi Business Overview 11.4.3 Sanofi After Acute Ischemic Stroke Introduction 11.4.4 Sanofi Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.4.5 Sanofi Recent Development 11.5 Biogen 11.5.1 Biogen Company Details 11.5.2 Biogen Business Overview 11.5.3 Biogen After Acute Ischemic Stroke Introduction 11.5.4 Biogen Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.5.5 Biogen Recent Development 11.6 Daiichi Sankyo 11.6.1 Daiichi Sankyo Company Details 11.6.2 Daiichi Sankyo Business Overview 11.6.3 Daiichi Sankyo After Acute Ischemic Stroke Introduction 11.6.4 Daiichi Sankyo Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.6.5 Daiichi Sankyo Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer After Acute Ischemic Stroke Introduction 11.7.4 Pfizer Revenue in After Acute Ischemic Stroke Business (2016-2021) 11.7.5 Pfizer Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global After Acute Ischemic Stroke Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antihypertensive Therapeutics Table 3. Key Players of Antiplatelet Therapeutics Table 4. Key Players of Anticoagulants Table 5. Global After Acute Ischemic Stroke Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global After Acute Ischemic Stroke Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global After Acute Ischemic Stroke Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global After Acute Ischemic Stroke Market Share by Regions (2016-2021) Table 9. Global After Acute Ischemic Stroke Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global After Acute Ischemic Stroke Market Share by Regions (2022-2027) Table 11. After Acute Ischemic Stroke Market Trends Table 12. After Acute Ischemic Stroke Market Drivers Table 13. After Acute Ischemic Stroke Market Challenges Table 14. After Acute Ischemic Stroke Market Restraints Table 15. Global After Acute Ischemic Stroke Revenue by Players (2016-2021) & (US$ Million) Table 16. Global After Acute Ischemic Stroke Market Share by Players (2016-2021) Table 17. Global Top After Acute Ischemic Stroke Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in After Acute Ischemic Stroke as of 2020) Table 18. Ranking of Global Top After Acute Ischemic Stroke Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by After Acute Ischemic Stroke Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players After Acute Ischemic Stroke Product Solution and Service Table 22. Date of Enter into After Acute Ischemic Stroke Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global After Acute Ischemic Stroke Market Size by Type (2016-2021) (US$ Million) Table 25. Global After Acute Ischemic Stroke Revenue Market Share by Type (2016-2021) Table 26. Global After Acute Ischemic Stroke Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global After Acute Ischemic Stroke Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global After Acute Ischemic Stroke Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global After Acute Ischemic Stroke Revenue Market Share by Application (2016-2021) Table 30. Global After Acute Ischemic Stroke Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global After Acute Ischemic Stroke Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America After Acute Ischemic Stroke Market Size by Type (2016-2021) (US$ Million) Table 33. North America After Acute Ischemic Stroke Market Size by Type (2022-2027) & (US$ Million) Table 34. North America After Acute Ischemic Stroke Market Size by Application (2016-2021) (US$ Million) Table 35. North America After Acute Ischemic Stroke Market Size by Application (2022-2027) & (US$ Million) Table 36. North America After Acute Ischemic Stroke Market Size by Country (2016-2021) & (US$ Million) Table 37. North America After Acute Ischemic Stroke Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe After Acute Ischemic Stroke Market Size by Type (2016-2021) (US$ Million) Table 39. Europe After Acute Ischemic Stroke Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe After Acute Ischemic Stroke Market Size by Application (2016-2021) (US$ Million) Table 41. Europe After Acute Ischemic Stroke Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe After Acute Ischemic Stroke Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe After Acute Ischemic Stroke Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific After Acute Ischemic Stroke Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific After Acute Ischemic Stroke Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific After Acute Ischemic Stroke Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific After Acute Ischemic Stroke Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific After Acute Ischemic Stroke Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific After Acute Ischemic Stroke Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America After Acute Ischemic Stroke Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America After Acute Ischemic Stroke Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America After Acute Ischemic Stroke Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America After Acute Ischemic Stroke Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America After Acute Ischemic Stroke Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America After Acute Ischemic Stroke Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa After Acute Ischemic Stroke Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa After Acute Ischemic Stroke Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa After Acute Ischemic Stroke Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa After Acute Ischemic Stroke Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa After Acute Ischemic Stroke Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa After Acute Ischemic Stroke Market Size by Country (2022-2027) & (US$ Million) Table 62. Bayer Company Details Table 63. Bayer Business Overview Table 64. Bayer After Acute Ischemic Stroke Product Table 65. Bayer Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 66. Bayer Recent Development Table 67. Boehringer Ingelheim Company Details Table 68. Boehringer Ingelheim Business Overview Table 69. Boehringer Ingelheim After Acute Ischemic Stroke Product Table 70. Boehringer Ingelheim Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 71. Boehringer Ingelheim Recent Development Table 72. Roche Company Details Table 73. Roche Business Overview Table 74. Roche After Acute Ischemic Stroke Product Table 75. Roche Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 76. Roche Recent Development Table 77. Sanofi Company Details Table 78. Sanofi Business Overview Table 79. Sanofi After Acute Ischemic Stroke Product Table 80. Sanofi Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 81. Sanofi Recent Development Table 82. Biogen Company Details Table 83. Biogen Business Overview Table 84. Biogen After Acute Ischemic Stroke Product Table 85. Biogen Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 86. Biogen Recent Development Table 87. Daiichi Sankyo Company Details Table 88. Daiichi Sankyo Business Overview Table 89. Daiichi Sankyo After Acute Ischemic Stroke Product Table 90. Daiichi Sankyo Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 91. Daiichi Sankyo Recent Development Table 92. Pfizer Company Details Table 93. Pfizer Business Overview Table 94. Pfizer After Acute Ischemic Stroke Product Table 95. Pfizer Revenue in After Acute Ischemic Stroke Business (2016-2021) & (US$ Million) Table 96. Pfizer Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global After Acute Ischemic Stroke Market Share by Type: 2020 VS 2027 Figure 2. Antihypertensive Therapeutics Features Figure 3. Antiplatelet Therapeutics Features Figure 4. Anticoagulants Features Figure 5. Global After Acute Ischemic Stroke Market Share by Application: 2020 VS 2027 Figure 6. Hospitals Case Studies Figure 7. Ambulatory Surgical Center Case Studies Figure 8. Diagnostic Centers Case Studies Figure 9. After Acute Ischemic Stroke Report Years Considered Figure 10. Global After Acute Ischemic Stroke Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global After Acute Ischemic Stroke Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global After Acute Ischemic Stroke Market Share by Regions: 2020 VS 2027 Figure 13. Global After Acute Ischemic Stroke Market Share by Regions (2022-2027) Figure 14. Global After Acute Ischemic Stroke Market Share by Players in 2020 Figure 15. Global Top After Acute Ischemic Stroke Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in After Acute Ischemic Stroke as of 2020 Figure 16. The Top 10 and 5 Players Market Share by After Acute Ischemic Stroke Revenue in 2020 Figure 17. Global After Acute Ischemic Stroke Revenue Market Share by Type (2016-2021) Figure 18. Global After Acute Ischemic Stroke Revenue Market Share by Type (2022-2027) Figure 19. North America After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America After Acute Ischemic Stroke Market Share by Type (2016-2027) Figure 21. North America After Acute Ischemic Stroke Market Share by Application (2016-2027) Figure 22. North America After Acute Ischemic Stroke Market Share by Country (2016-2027) Figure 23. United States After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe After Acute Ischemic Stroke Market Share by Type (2016-2027) Figure 27. Europe After Acute Ischemic Stroke Market Share by Application (2016-2027) Figure 28. Europe After Acute Ischemic Stroke Market Share by Country (2016-2027) Figure 29. Germany After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific After Acute Ischemic Stroke Market Share by Type (2016-2027) Figure 37. Asia-Pacific After Acute Ischemic Stroke Market Share by Application (2016-2027) Figure 38. Asia-Pacific After Acute Ischemic Stroke Market Share by Region (2016-2027) Figure 39. China After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America After Acute Ischemic Stroke Market Share by Type (2016-2027) Figure 47. Latin America After Acute Ischemic Stroke Market Share by Application (2016-2027) Figure 48. Latin America After Acute Ischemic Stroke Market Share by Country (2016-2027) Figure 49. Mexico After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa After Acute Ischemic Stroke Market Share by Type (2016-2027) Figure 53. Middle East & Africa After Acute Ischemic Stroke Market Share by Application (2016-2027) Figure 54. Middle East & Africa After Acute Ischemic Stroke Market Share by Country (2016-2027) Figure 55. Turkey After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE After Acute Ischemic Stroke Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Bayer Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 59. Boehringer Ingelheim Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 60. Roche Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 61. Sanofi Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 62. Biogen Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 63. Daiichi Sankyo Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 64. Pfizer Revenue Growth Rate in After Acute Ischemic Stroke Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Bayer Boehringer Ingelheim Roche Sanofi Biogen Daiichi Sankyo Pfizer